Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis
Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis have?
Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis has 115 citations in the OpenAlex counts ScholarIQ stores.
When was Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis published?
Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis has 2012 year in the ScholarIQ index.
What is the open-access status of Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis?
Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis has bronze oa status in the ScholarIQ index.
What is the DOI of Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis?
The DOI for Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis is on the source record.
What is the PMID of Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis?
The PMID for Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis is on the source record.
What is the OpenAlex record for Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis?
The OpenAlex for Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis is on the source record.